- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02024750
Tailored Diabetes Self-Management Resources
Family-Centered Tailoring of Pediatric Diabetes Self-Management Resources
Children with type 1 diabetes face complex self-management regimens which make adherence challenging and ultimately result in poor blood sugar control. Several common barriers interfere with diabetes control such as limited knowledge or challenges with staying motivated. Efficacious strategies exist to improve diabetes self-management including, but not limited to, diabetes education or family therapy. Patients and families often do not access these strategies, in part due to healthcare systems-based issues such as accessibility, provider availability, or insurance coverage.
A family-centered approach has been suggested to tailor diabetes care to provide improved outcomes for each child. Family-centered care engages the family in the decision-making about the child's health and well-being. In this study we will take a family-centered approach to providing diabetes self-management by identifying families' unique self-management barriers through a 10-minute survey tool called PRISM (Problem Recognition in Illness Self-Management). Based upon the results of PRISM, we will provide tailored self-management resources (interventions) to meet the family's needs. We will coordinate group-based delivery of the resources with routine diabetes clinic visits. These group-based resources will be delivered in four 75-minute sessions over a year.
The primary goal of this study is to compare the effectiveness of family-centered tailoring of diabetes self-management resources with the untailored approach of usual care. We hypothesize that the family-centered model of care with tailored resources will improve the outcomes of glycemic control and quality of life among children with type 1 diabetes and their parents.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This project's long-term goal is to develop a system-level method to move existing, efficacious self-management resources into the hands of children with type 1 diabetes and their families. Over 175,000 US children have type 1 diabetes and face a lifetime of self-management decisions in an attempt to delay or prevent complications, avoid hypoglycemia, and maintain quality of life for themselves and their parents. Although efficacious self-management resources exist, most children with diabetes struggle to manage their disease. Several barriers to diabetes management exist, including knowledge, motivation, and family interactions. Because barriers are unique for each child and family, family-centered approaches are recommended. Currently, no systematic approach exists to identify and address each family's self-management barriers. Information from PRISM (Problem Recognition in Illness Self-Management), a 10-minute survey tool, could help families and clinicians make better decisions to address these barriers, ultimately improving outcomes, fostering family-centered diabetes care, and optimizing resource use.
This randomized, pragmatic trial will compare outcomes from PRISM-based, family-centered tailoring of self-management resources (intervention) to outcomes from the untailored approach of usual care. Our specific aims are to assess the effect of family-centered tailoring of diabetes self-management resources on outcomes that matter to the children and parents: glycemic control (A1c and fear of hypoglycemia) and child and parent quality of life.
Children 8-16 years old with diabetes (150 each in usual care and intervention groups) and their parents will be enrolled at two large pediatric diabetes clinics. We will 1) use PRISM to identify families' unique self-management barriers; 2) tailor self-management resources to identified barriers; and 3) coordinate group-based delivery of the resources with routine diabetes visits. The group-based resources will be delivered in four 75-minute sessions over 12 months. A1c will be assessed after sessions, along with fear of hypoglycemia and quality of life for the child and parent. We will compare outcomes with mixed-effects models.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- University of Wisconsin - Madison
-
Milwaukee, Wisconsin, United States, 53201
- Children's Hospital of Wisconsin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children and adolescents with type 1 diabetes and their parents who receive care at one of two sites in Wisconsin.
- Planning to continue care at clinic for the next 2 years.
- English speaking
- Diagnosed with diabetes for > 12 months
Exclusion Criteria:
- Newly diagnosed with diabetes (< 12 months)
- Participant in prior preliminary work for this study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Tailored Resources
Use of PRISM screening tool to identify self-management needs and to provide tailored group session resources over 1 year
|
Based upon PRISM screening tool results that identifies self-management barriers, patient/family will receive self-management resources matched to their barriers.
These resources could be focused on: 1. Understanding and organizing care; 2. Motivation to self-manage; and 3. Family Teamwork.
Group session of about 6 families with the same barrier will meet four times fo 75-minutes over a year, at the clinic site on same date as routine clinic visit.
|
NO_INTERVENTION: Usual Care
Patients and families obtain routine multidisciplinary diabetes care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Hemoglobin A1c for Usual Care and Tailored Resources (Intervention) Arms, During and Post-Intervention
Time Frame: Up to 5 time points during the intervention (12 months) and up to 4 time points in the post-intervention period (12 months)
|
Mean change in A1c per month (slope), during and post-intervention.
|
Up to 5 time points during the intervention (12 months) and up to 4 time points in the post-intervention period (12 months)
|
Change in Child Quality of Life (QOL) for Usual Care and Tailored Resources (Intervention) Arms, During and Post-Intervention
Time Frame: Up to 2 time points during the intervention (12 months) and up to 3 time points in the post-intervention period (12 months)
|
Mean change in child quality of life per month (slope), during and post-intervention.
Child quality of life is measured by the PedsQL Diabetes Module.
Possible scores range from 0 to 100 with higher scores indicating better quality of life.
Positive slopes reflect improving quality of life.
|
Up to 2 time points during the intervention (12 months) and up to 3 time points in the post-intervention period (12 months)
|
Change in Parent Quality of Life (QOL) for Usual Care and Tailored Resources (Intervention) Arms, During and Post-Intervention
Time Frame: Up to 2 time points during the intervention (12 months) and up to 3 time points in the post-intervention period (12 months)
|
Mean change in parent quality of life per month (slope), during and post-intervention.
Parent quality of life is measured by the PedsQL Family Impact Module.
Possible scores range from 0 to 100 with higher scores indicating better quality of life.
Positive slopes reflect improving quality of life.
|
Up to 2 time points during the intervention (12 months) and up to 3 time points in the post-intervention period (12 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change In Parent Fear of Hypoglycemia (FOH) for Usual Care and Tailored Resources (Intervention) Arms, During and Post-Intervention
Time Frame: Up to 2 time points during the intervention (12 months) and up to 2 time points in the post-intervention period (12 months)
|
Mean change in parent fear of hypoglycemia per month (slope), during and post-intervention.
Parent fear of hypoglycemia is measured by the Hypoglycemia Fear Survey Worry Subscale.
Possible scores range from 15 to 75 with higher scores indicating greater fear of hypoglycemia.
Positive slopes reflect increasing fear of hypoglycemia.
|
Up to 2 time points during the intervention (12 months) and up to 2 time points in the post-intervention period (12 months)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Elizabeth D Cox, MD,PhD, University of Wisconsin, Madison
Publications and helpful links
General Publications
- Fiallo-Scharer R, Palta M, Chewning BA, Rajamanickam V, Wysocki T, Wetterneck TB, Cox ED. Impact of family-centered tailoring of pediatric diabetes self-management resources. Pediatr Diabetes. 2019 Nov;20(7):1016-1024. doi: 10.1111/pedi.12899. Epub 2019 Aug 8.
- Fiallo-Scharer R, Palta M, Chewning BA, Wysocki T, Wetterneck TB, Cox ED. Design and baseline data from a PCORI-funded randomized controlled trial of family-centered tailoring of diabetes self-management resources. Contemp Clin Trials. 2017 Jul;58:58-65. doi: 10.1016/j.cct.2017.04.007. Epub 2017 Apr 24.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013-1506
- MSN164403 (OTHER: Patient-Centered Outcomes Research Institute)
- IRB 00016300 (OTHER: Study Team)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 1
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of California, San FranciscoJuvenile Diabetes Research FoundationCompletedType 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMUnited States, Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
Spiden AGDCB Research AGRecruitingType 1 Diabetes Mellitus | Type 1 Diabetes Mellitus With Hypoglycemia | Type 1 Diabetes Mellitus With HyperglycemiaSwitzerland
-
Instytut Diabetologii Sp. z o.o.National Center for Research and Development, Poland; Nalecz Institute of Biocybernetics...UnknownType 1 Diabetes Mellitus With Hyperglycemia | Type 1 Diabetes Mellitus With HypoglycaemiaPoland
Clinical Trials on Tailored Resources
-
Unity Health TorontoOntario Ministry of Health and Long Term Care; Ontario Medical Association; Platinum... and other collaboratorsRecruitingQuality of Life | Mental Health | Emotional DistressCanada
-
University of WashingtonNational Institute of Mental Health (NIMH); Mental Health America; TalkspaceRecruiting
-
New York State Psychiatric InstituteThe Robin Hood FoundationCompletedPostpartum Depression | Infant Development | Rhythm; SleepUnited States
-
University of CologneUnknown
-
Children's Hospital of Eastern OntarioHeart and Stroke Foundation of Ontario; Variety Village; City of Toronto Parks...CompletedCardiomyopathy | Congenital Heart Defects | Inherited Cardiac ArrhythmiasCanada
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...CompletedAnalysis of Neuromuscular Responses and the Balance After the Application of Physiotherapy ResourcesCryotherapy Effect | Musculoskeletal Injuries | Complication of Diathermy ProcedureBrazil
-
Abramson Cancer Center at Penn MedicineUniversity of FloridaRecruitingCommunication Research | Adolescent Behavior | VapingUnited States
-
Massachusetts General HospitalCompletedBurnout, ProfessionalUnited States
-
Arizona State UniversityMayo Clinic; University of ArizonaCompletedColorectal CancerUnited States
-
University of Social Sciences and Humanities, WarsawLinkoeping University; Stockholm UniversityCompletedBurnout, Professional | Stress, Psychological, OccupationalPoland